- Before
- Builds each market’s playbook by hand from the content library, product information and CRM — a median of 5.4 days each.
- Now
- Picks region, product and audience, checks a playbook assembled from approved modules with every section sourced, and signs.
One playbook, from three choices to live in CRM
Klinikum Rheinhafen’s drug committee meets on Oct 22, and the last call, on Sep 18, ended with a question: can Veltrimab pens be kept as ward stock at room temperature? Here is how the playbook for that meeting is built, signed and kept current, screen by screen, in the working solution.
- 01Morning
What needs the playbook owner today
Lena Ortiz · Commercial excellence leadLena opens the solution: 146 playbooks live in CRM across 7 regions, 3 products and 6 audiences, 1 ready to sign, 4 needing a refresh, and 412 rep questions this week, 94% answered with a citation. The list under “Needs you” shows what each item is waiting for.
“Veltrimab product information — version 7 · Stability after dilution changed · 4 playbooks quote the old wording”
- 02Three choices
Region, product, the person the rep will meet
Lena Ortiz · Playbook ownerLena picks Germany (58 reps), Veltrimab and Hospital pharmacist, and the account Klinikum Rheinhafen. 38 approved modules match. Before anything is built, the builder shows what it will leave out — DE-VEL-0371, expired Sep 30; DE-VEL-0388, withdrawn for its old stability wording; US-VEL-0207, approved for the US only — and that the Pflichttext will be added for Germany.
Audiences with no approved content for the product, such as Cardiologist for Veltrimab, cannot be picked: “No approved content”.
- 032.8 seconds later
PB-2047, assembled from 10 approved modules
Playbook assembler and Compliance checkThe agent run is shown step by step: the CRM account read, 38 approved modules found, 3 left out, 9 sections assembled with the wording unchanged, compliance check passed. The account snapshot opens the playbook — 1,150 beds, IBD centre, Dr. Petra Lindqvist as chief pharmacist, drug committee on Oct 22, 212 patients on IBD biologics — and the ward-stock question from the last call is answered in section 3.
“Built only from approved, in-date modules — wording is unchanged, so Medical and Legal approval carries over. Your sign-off publishes it.”
- 04Before signing
The question a pharmacist will ask, answered from the SmPC
Lena Ortiz · Playbook ownerBeside the playbook, Lena asks the SOP assistant what a rep can say about storage outside the fridge. The answer comes from 3 passages in 3 documents in 0.9 s: up to 30 °C for a single period of up to 30 days in the carton, never back in the fridge. Anything beyond that is a medical question, logged as a medical information request in CRM during the call.
The answer ends with the approved wording to say, from module DE-VEL-0418.
- 05One click
Every citation opens at its passage
Lena Ortiz · Playbook ownerA numbered citation opens the source with the passage highlighted: section 6.4 of the Veltrimab product information, version 7, effective 1 Oct 2026, and section 5 of SOP-COM-031 Communicating product handling. The same works for every source chip under every section of the playbook.
- 06Signed
Sign and publish to CRM
Lena Ortiz · Playbook ownerThe sign-off screen lists what Lena is signing: 10 approved modules, all in date, next expiry Mar 12, 2028, nothing within 14 days; the Pflichttext for Germany included; the compliance check passed; publishing to the Germany hospital team, 58 reps, on the account tab and next call plan. She chooses the reason — “Approved for field use” — and enters her password.
“Your signature, the reason and the time are recorded on the audit trail.”
- 07Live
On the account, in Jonas’s next call plan
CRM publisherPB-2047 is live for 58 reps. In CRM, on the Klinikum Rheinhafen account and Jonas Weber’s call plan for Oct 14 at 10:30, the rep sees the opening line in approved wording, the talking points, what to keep on label, the approved materials to share and the SOP assistant. The footer reads “v1 · 10 approved modules · published Oct 6”.
- 08When the label changes
The playbooks that quote superseded wording, found
Content freshness checkerVersion 7 of the product information changed section 6.3: the diluted infusion is now stable for 8 hours at room temperature, not 4. Omar Haddad withdrew module DE-VEL-0388 on Oct 1 and DE-VEL-0421 was approved by Medical and Legal the same day. The freshness checker found the 4 live playbooks that still quote the old wording.
- 09One click
Refreshed — and back to the owners to sign
Content freshness checker“Refresh 4 playbooks” swaps DE-VEL-0388 for DE-VEL-0421 and its local equivalents, reruns the compliance check and sends each playbook to its owner — Lena Ortiz, Marco Bellini, Lucía Romero and Sam Patel. Nothing changes in the field until they sign.
The freshness checker never edits a live playbook without sign-off.
- 1008:15, in the field
An off-label question goes to Medical Information
Miriam Kraus · Rep, GermanyA pharmacist asks Miriam about use in children. The assistant answers that Veltrimab is approved for adults only, that field colleagues never answer off-label questions, and how to pass it on: capture the question word for word with the pharmacist’s consent and submit it in CRM. It cites SOP-MED-022 and offers “Log medical information request”.
“They acknowledge within 1 business day.”